| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/27/2002 | US6440730 Retroviral hybrid vectors pseudotyped with LCMV |
| 08/27/2002 | US6440702 For treatment of motor neuron diseases and muscle degenerative diseases; screening for therapeutic proteins by determining altered electrophoretic binding properties |
| 08/27/2002 | US6440701 Transferrin receptor genes of Moraxella |
| 08/27/2002 | US6440700 Method of combinatorial protein synthesis based on ribosomal frameshifting |
| 08/27/2002 | US6440698 Amyloid precursor proteins for identifying candidate therapeutics |
| 08/27/2002 | US6440694 Which is a tumor necrosis factor (tnf) homolog of given nucleotide sequence and amino acid sequence |
| 08/27/2002 | US6440688 Organism transformed to express said enzyme; oxidizes nad to nadh and reduces nadph to nadp, for use as biocatalyst in reacting morphine to hydromorphone |
| 08/27/2002 | US6440680 Using dna encoding the novel prostaglandin receptor and host cells expressing the receptor |
| 08/27/2002 | US6440452 Therapeutic enclosures |
| 08/27/2002 | US6440424 High molecular weight major outer membrane protein of moraxella |
| 08/27/2002 | US6440422 Expressing foreign genes inserted at site of naturally occurring deletion in modified vaccinia virus ankara genome; polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy; encoding antigens as vaccines |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440407 Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides |
| 08/27/2002 | CA2264270C Mass production of paclitaxel by changing the temperature of the medium during the plant cell culture |
| 08/27/2002 | CA2231738C Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same |
| 08/27/2002 | CA2125403C Novel tissue plasminogen activator variants |
| 08/27/2002 | CA2069929C Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 08/22/2002 | WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | WO2002064804A2 A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes |
| 08/22/2002 | WO2002064802A2 Regulatory genes suitable for use in gene expression |
| 08/22/2002 | WO2002064795A2 Putative human enzymes |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064791A2 Proteins and nucleic acids encoding same |
| 08/22/2002 | WO2002064790A2 Jfy1 protein induces rapid apoptosis |
| 08/22/2002 | WO2002064788A2 Compositions and methods relating to lung specific genes and proteins |
| 08/22/2002 | WO2002064787A1 Neurotonin and use thereof |
| 08/22/2002 | WO2002064785A1 NOVEL CLOCK GENE Bmal2 |
| 08/22/2002 | WO2002064763A1 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/22/2002 | WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/22/2002 | WO2002064756A2 Stem cell identification |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064754A2 Medium for culturing tumour cells |
| 08/22/2002 | WO2002064753A1 Method for the production of a biological tissue using a collagen support and corresponding tissue construct |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064747A2 Fusion proteins based upon somatostatin receptors |
| 08/22/2002 | WO2002064742A2 Compounds effecting neuron remodeling and assays for same |
| 08/22/2002 | WO2002064740A2 Cone snail peptides |
| 08/22/2002 | WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | WO2002064728A2 Incubator and incubation method monitoring the organism to be incubated |
| 08/22/2002 | WO2002064666A2 Substrates containing polyphosphazene as matrixs and with a microstructured surface |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064631A2 T1r taste receptors and genes encoding same |
| 08/22/2002 | WO2002064629A2 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
| 08/22/2002 | WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/22/2002 | WO2002064625A1 Matrix gene expression in chondrogenesis |
| 08/22/2002 | WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | WO2002064615A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 08/22/2002 | WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | WO2002064610A1 Polynucleotide constructs for increased lysine production |
| 08/22/2002 | WO2002064179A2 Bioartificial primarily vascularized tissue matrix, bioartificial primarily vascularized tissue, method for the production thereof and use of the same |
| 08/22/2002 | WO2002064164A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 08/22/2002 | WO2002064158A2 Use of a conjugate of il-6 and the receptor thereof for inducing cellular expression of scf and flt-3l |
| 08/22/2002 | WO2002064152A1 Cardiomyocytes and methods of culture of same |
| 08/22/2002 | WO2002064131A2 Inflammation-inhibiting compounds |
| 08/22/2002 | WO2002064092A2 Method for evaluating therapeutic efficacy |
| 08/22/2002 | WO2002064018A2 Immortalized human familial prostatic cancer cell lines |
| 08/22/2002 | WO2002064017A2 Immortalized human prostatic cancer cell lines |
| 08/22/2002 | WO2002063962A1 Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| 08/22/2002 | WO2002063959A1 Methods and compositions for stimulating axon regeneration and prventing neuronal cell degeneration |
| 08/22/2002 | WO2002063938A2 Production and use of dopaminergic cells to treat dopaminergic deficiencies |
| 08/22/2002 | WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2002044361A3 Eukaryotic expression libraries based on double lox recombination and methods of use |
| 08/22/2002 | WO2002036170A3 Vector system for transducing the positive neurons |
| 08/22/2002 | WO2002033050A3 Methods and compositions for promoting the maturation of monocytes |
| 08/22/2002 | WO2002015939A3 Calycins |
| 08/22/2002 | WO2002010394A3 Nucleic acids, by means of which plants with altered metabolite content can be produced |
| 08/22/2002 | WO2002002773A3 Dual specificity antibodies and methods of making and using |
| 08/22/2002 | WO2002000233A3 Purging of cells using viruses |
| 08/22/2002 | WO2001094944A3 Artificial antigen presenting cells and methods of use thereof |
| 08/22/2002 | WO2001075143A3 Sigma binding region of rna polymerase and uses thereof |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2001072295A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2001042506A9 T1 receptor-like ligand ii and uses thereof |
| 08/22/2002 | WO2000036092A9 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 08/22/2002 | WO2000023465A9 Methods and reagents for isolating biologically active peptides |
| 08/22/2002 | WO2000014200A9 Essential bacterial genes and their use |
| 08/22/2002 | WO1999058143A9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/22/2002 | US20020116731 Expression vector coding polypeptide for use in the treatment of diabetes |
| 08/22/2002 | US20020116726 Muir-torre-like syndrome in Fhit deficient mice |
| 08/22/2002 | US20020116725 Method to increase cerebral blood flow in amyloid angiopathy |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020115850 Expression vector for use in generation of disease resistant plants |
| 08/22/2002 | US20020115849 Plant promoter activated by fungal infection |
| 08/22/2002 | US20020115843 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 08/22/2002 | US20020115829 Pathogenic escherichia coli associated protein |
| 08/22/2002 | US20020115681 Anticholinergics which have a long-lasting effect, such as glycopyrronium bromide, tiotropium bromide or an ester of bi-or tricyclic amino alcohol such as a nortropanol |
| 08/22/2002 | US20020115647 Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| 08/22/2002 | US20020115627 Phosphatonin-related gene and methods of use thereof |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |
| 08/22/2002 | US20020115223 In vitro system for determining formation of abeta amyloid |
| 08/22/2002 | US20020115219 Transforming cell with preferential nucleotide sequences; obtain cell, bore aperature in cell wall or mem brane, transform with nucleotide sequences recover transformed cells |
| 08/22/2002 | US20020115218 Gene delivery vectors with cell type specificity for primary human chondrocytes |
| 08/22/2002 | US20020115214 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation |
| 08/22/2002 | US20020115213 Engraftable neural progenitor & stem cells for brain tumor therapy |
| 08/22/2002 | US20020115212 Cell culture for use in the generation of antitumor agents |
| 08/22/2002 | US20020115211 In vitro fertilization of human oocytes; obtain cells, incubate in nutrient broths, feterlize cells, propagate |
| 08/22/2002 | US20020115210 Vectors and methods for the mutagenesis of mammalian genes |
| 08/22/2002 | US20020115208 Decellularized tissue engineered constructs and tissues |
| 08/22/2002 | US20020115206 Established cell line of microglia |
| 08/22/2002 | US20020115201 Microfluidic devices with monolithic microwave integrated circuits |